Atlas Trials

Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Clinical trial NCT00478426 · COMPLETED

Trial details

NCT number
NCT00478426
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial AdenocarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Serous AdenocarcinomaRecurrent Uterine Corpus CarcinomaStage IVA Uterine Corpus Cancer AJCC v7Stage IVB Uterine Corpus Cancer AJCC v7Uterine CarcinosarcomaUterine Corpus Carcinosarcoma
Start date
2007-04-30
Primary completion
2019-02-12
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.